Order results by:
| Issue | Title | |
| Vol 20, No 4 (2024) | Increased lipoprotein (a) as an additional factor in the failure to achieve target blood pressure levels and lipid spectrum optimal parameters in patients with arterial hypertension and multifocal atherosclerosis | Abstract similar documents |
| S. S. Vedenskaya, O. G. Smolenskaya | ||
| "... received antihypertensive, lipid-lowering, and antiplatelet therapy. Results. Patients in groups 1 and 2 ..." | ||
| Vol 12, No 3 (2016) | EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY | Abstract PDF (Eng) similar documents |
| E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz | ||
| "... cover issues of efficacy and safety of lipid-lowering therapy in primary and secondary prevention ..." | ||
| Vol 14, No 3 (2018) | THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova | ||
| "... of atherosclerotic lesion and the severity of stenosis are described. The target blood lipids levels in the treatment ..." | ||
| Vol 11, No 5 (2015) | Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation | Abstract similar documents |
| E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov | ||
| "... (n=19; 57.6%) compared with the group TCZ+MTX (n=7; 18%), (p<0.05). The lipid levels correlated ..." | ||
| Vol 9, No 2 (2013) | MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) | Abstract similar documents |
| S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina | ||
| "... Aim. To assess the quality of lipid-lowering therapy in high risk patients with cardiovascular ..." | ||
| Vol 13, No 5 (2017) | AGE AND GENDER PECULIARITIES OF BLOOD LIPIDS IN URBAN RESIDENTS (CROSS-SECTIONAL STUDY RESULTS) | Abstract similar documents |
| S. A. Urazgildeeva, M. Yu. Nizhegorodcev, P. S. Sadovnikov, A. Yu. Olkhovik, D. Yu. Nokhrin, M. V. Muzalevskaya, I. V. Shugurova, D. G. Malenkovskaya, A. V. Tregubov, V. S. Gurevich | ||
| "... Aim. To analyze the results of measurements of the blood lipid spectrum of urban residents ..." | ||
| Vol 11, No 5 (2015) | Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis | Abstract similar documents |
| N. E. Gavrilova, V. A. Metelskaya, E. B. Yarovaya, N. V. Gomyranova, S. A. Boytsov | ||
| "... Aim. To assess of lipid-lowering therapy with statins in very high cardiovascular risk patients ..." | ||
| Vol 14, No 5 (2018) | Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation | Abstract similar documents |
| Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov | ||
| "... Aim. To assess the economic burden associated with the absence of lipid-lowering therapy (LLT ..." | ||
| Vol 16, No 1 (2020) | Deprescribing Antihypertensive Drugs in Patients of Older Age Groups | Abstract similar documents |
| O. D. Ostroumova, M. S. Cherniaeva, D. A. Sychev | ||
| "... guidelines for the treatment of AH determine specific approaches for managing patients of older age groups ..." | ||
| Vol 2, No 3 (2006) | EFFECT OF CYTOPROTECTION ON THE OXIDATIVE PROCESSES AND ENDOTHELIAL FUNCTION IN ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. V. Shabalin, Yu. I. Ragino, S. A. Lyubimtseva, Ya. V. Polonskaya, M. V. Ivanova | ||
| "... arterial hypertension (AH). All patients were randomized into 2 groups: 1) 67 patients (75,4±0,5 y. o ..." | ||
| Vol 3, No 3 (2007) | THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| I. V. Sergienko, V. V. Kukharchuk, S. A. Gabrusenko, V. V. Malakhov, V. P. Masenko, M. I. Tripoten, T. V. Balahonova | ||
| "... Aim. To study the effect of treatment with metabolic corrector mildronate on lipid profile ..." | ||
| Vol 6, No 1 (2010) | PECULIARITIES OF PURINE METABOLISM AND LIPID PEROXIDATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | Abstract similar documents |
| E. V. Horolets, L. A. Haisheva, S. V. Shlyk, L. I. Katelnitskaya | ||
| "... Aim. To study purine metabolism and lipid peroxidation in patients with acute myocardial ..." | ||
| Vol 3, No 1 (2007) | EFFECTS OF METABOLIC DRUG ELTACINE ON CLINICAL, FUNCTIONAL AND BIOCHEMICAL INDICES IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| R. M. Zaslavskaya, G. V. Lilitsa, Ye. V. Kalinina, I. A. Komissarova, L. N. Maximova | ||
| "... randomized in two parallel groups of patients receiving Eltacine or placebo additionally to standard therapy ..." | ||
| Vol 20, No 6 (2024) | The impact of clinical decision support systems on adherence to clinical guidelines and achieving target levels of low-density lipoprotein cholesterol in patients at risk of developing cardiovascular events (SuccESS) | Abstract similar documents |
| K. S. Astrakova (Benimetskaya), I. L. Mikheenko, A. E. Uranov, A. A. Gartung, E. A. Kovalev, A. A. Spiridonov, I. I. Shestova, I. L. Strokolskaya, M. A. Meshkova, L. I. Esev, А. V. Reznik, V. А. Petrakovskaia, A. M. Shangina, Yu. E. Efremova, I. V. Sergienko, M. V. Ezhov, O. L. Barbarash, P. N. Paleev | ||
| Vol 14, No 3 (2018) | HYPOLIPIDEMIC THERAPY IN STROKE PREVENTION: EXISTING STANDARDS, EVIDENCE-BASED MEDICINE DATA AND REAL PRACTICE | Abstract similar documents |
| O. V. Gaisenok, A. N. Rozhkov, A. S. Lishuta | ||
| "... . The issues of lipid-lowering therapy with statins in the aspect of stroke prevention are discussed ..." | ||
| Vol 18, No 3 (2022) | Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER | Abstract similar documents |
| I. A. Zolotovskaya, V. P. Kuzmin, O. A. Rubanenko, P. R. Shatskaya, A. S. Salasyuk | ||
| "... frequent use of angiotensin II receptor blockers in group 2, p<0.05), lipid profile and blood pressure ..." | ||
| Vol 6, No 4 (2010) | EFFECTS OF ACUTE PHYSICAL EXERCISE OF VARYING INTENSITY ON LIPID METABOLISM IN MIDDLE AGED MEN | Abstract similar documents |
| G. E. Roytberg, I. D. Slastnikova, O. Ju. Dmitrieva, T. I. Ushakova | ||
| "... , and atherogenic index). Effect of physical exercise on the lipid profile as studied both in the whole group ..." | ||
| Vol 6, No 1 (2010) | EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS | Abstract PDF (Eng) similar documents |
| D. M. Aronov, V. B. Krasnitskij, M. G. Bubnova | ||
| "... significant at intergroup comparison. Lipid-lowering drugs implementation was inadequate in both groups ..." | ||
| Vol 14, No 1 (2018) | THIRTY-YEAR CHANGES IN AVERAGE BLOOD LIPIDS LEVELS IN POPULATIONS OF THE RUSSIAN FEDERATION AND THE USA | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, V. G. Vilkov, V. A. Metelskaya, Yu. A. Balanova, A. V. Kapustina | ||
| "... Aim. To conduct a comparative study of the changes in blood lipids profiles in populations ..." | ||
| Vol 20, No 2 (2024) | Comparative placebo-controlled study on the effect of dietary supplements containing omega-3 polyunsaturated fatty acids on hemodynamics and lipid metabolism in postmenopausal women | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova, A. A. Kudrjavtseva, A. I. Skripka, A. V. Zhilenko, E. V. Kolpachkova, D. K. Varvarina | ||
| "... group and 7 (15.2%) patients from the placebo group took constant lipid- lowering therapy. The patients ..." | ||
| Vol 15, No 4 (2019) | The Association of Smoking Status and Intensity of Smoking with Blood Lipid Spectrum in a Sample of Middle-Aged Men | Abstract similar documents |
| A. A. Alexandrov, V. B. Rozanov, M. B. Kotova, V. A. Dadaeva, E. I. Ivanova | ||
| "... . The probability of being in a group with dyslipidemia was more than 2 times higher in smokers as compared to non ..." | ||
| Vol 2, No 2 (2006) | THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL | Abstract similar documents |
| Y. R. Kasherininov, E. K. Shavarova, A. A. Shavarov, N. V. Vachrameeva, A. N. Krutikov, E. V. Smirnova, A. O. Коnrady, E. V. Shlyakhto | ||
| "... group. Rilmenidine showed a positive effect on lipid levels, while in the atenolol group a significant ..." | ||
| Vol 6, No 6 (2010) | WORKING GROUP OF THE YOUNG CARDIOLOGISTS HAS BEEN ESTABLISHED AT THE SOCIETY OF CARDIOLOGY OF THE RUSSIAN FEDERATION | Abstract similar documents |
| "... Working group of the Young Cardiologists has been established at the Society of Cardiology ..." | ||
| Vol 17, No 6 (2021) | Factors Determining the Three-Year Dynamics of Lipid Metabolism Indicators in Residents of a Large Industrial Region of Siberia | Abstract similar documents |
| D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, A. S. Agienko, O. V. Nakhratova, G. V. Artamonova, O. L. Barbarash | ||
| "... by 8.6%. The prevalence of dyslipidemia increased in all socioeconomic groups. Conclusion. Over 3 ..." | ||
| Vol 12, No 6 (2016) | THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015 | Abstract PDF (Eng) PDF (Eng) similar documents |
| S. A. Smetnev, A. I. Ershova, R. S. Bogdanova, A. N. Meshkov, S. A. Boytsov | ||
| "... prescribed group of lipid-lowering drugs was statins, while combined treatment or monotherapy with other ..." | ||
| Vol 14, No 2 (2018) | MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
| L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov | ||
| "... after 24 weeks in the both groups. Conclusion. The revealed lipid-lowering and pleiotropic effects ..." | ||
| Vol 11, No 1 (2015) | ASPECTS OF LIPID-LOWERING THERAPY WITH ATORVASTATIN IN PATIENTS WITH MYOCARDIAL INFARCTION FROM THE PERSPECTIVE OF PERSONALIZED MEDICINE | Abstract similar documents |
| M. V. Solodun, S. S. Yakushin | ||
| "... . All patients were prescribed atorvastatin. A group of 65 people in whom lipid levels were studied ..." | ||
| Vol 11, No 3 (2015) | THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov | ||
| "... Aim. To evaluate the differences between a group of patients treated with ursodeoxycholic acid ..." | ||
| Vol 14, No 6 (2018) | The Role of PCSK9 Inhibitors in the Improvement of Outcomes in Patients after Acute Coronary Syndrome: Results of ODYSSEY OUTCOMES Trial | Abstract PDF (Eng) similar documents |
| Yu. A. Karpov | ||
| "... the event. The use of high-intensity statin therapy in this group of patients does not always lead ..." | ||
| Vol 14, No 1 (2018) | IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION | Abstract similar documents |
| I. V. Sergienko, A. A. Ansheles | ||
| "... in history in lipid-lowering therapy group (p<0.01). Patients with HCh and established ischemic heart disease ..." | ||
| Vol 6, No 3 (2010) | EFFECT OF COMPLEX HOMEOPATHIC DRUG CONTAINING COENZYME Q ON PARAMETERS OF OXIDATIVE STRESS AND HEMODYNAMICS IN EXPERIMANTAL DIABETES MELLITUS | Abstract similar documents |
| S. G. Dzugkoev, V. A. Metelskaya, I. V. Mozhaeva, F. S. Dzugkoeva | ||
| "... control group. The parameters of macro- and microhemodynamic, lipid peroxidation, Na,K-ATPase activity ..." | ||
| Vol 12, No 3 (2016) | ESTIMATION OF RIGHT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE IN DIFFERENT AGE GROUPS | Abstract PDF (Eng) similar documents |
| R. A. Gajfulin, A. N. Sumin, O. G. Arhipov | ||
| "... with ischemic heart disease (IHD) in different age groups. Material and methods. Patients (n=678) with IHD aged ..." | ||
| Vol 10, No 1 (2014) | ADHERENCE TO LONG-TERM TREATMENT OF CARDIOVASCULAR DISEASE AND NON-COMPLIANCE WITH MEDICAL RECOMMENDATIONS: THE OPINION OF PATIENTS AND PHYSICIANS BY THE RESULTS OF FOCUSED INTERVIEW | Abstract similar documents |
| O. N. Semenova, E. A. Naumova, Yu. G. Schwartz | ||
| "... with adherence to treatment for chronic cardiovascular diseases in the group focused interview of patients ..." | ||
| Vol 17, No 2 (2021) | Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 2: Treatment Options | Abstract similar documents |
| V. G. Grachev, S. S. Vedenskaya, O. G. Smolenskaya | ||
| "... in patients with multifocal arterial lesions using antihypertensive, antithrombotic and lipid-lowering therapy ..." | ||
| Vol 13, No 3 (2017) | SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION | Abstract similar documents |
| S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev | ||
| "... groups with a history of myocardial infarction by the example of outpatient cardiology institution ..." | ||
| Vol 7, No 5 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva | ||
| "... сердечных сокращений (ЧСС) относительно плацебо на всех этапах исследования. В группе больных, получавших ..." | ||
| Vol 4, No 1 (2008) | ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko | ||
| "... свете существующих международных рекомендаций. Затрагивается проблема выбора препарата из группы ..." | ||
| Vol 21, No 1 (2025) | Impact of hyperlipoproteinemia(a) on the diagnosis of familial hypercholesterolemia and cardiovascular risk assessment | Abstract similar documents |
| A. M. Namitokov, U. V. Chubykina, V. K. Zafiraki, M. V. Ezhov | ||
| "... ≥180 mg/dL. The diagnosis of heterozygous FH was confirmed using the Dutch Lipid Clinic Network (DLCN ..." | ||
| Vol 15, No 4 (2019) | Atrial Septal Aneurysm in Adult Patients of Therapeutic Hospital | Abstract similar documents |
| O. V. Ryazantseva, N. I. Lenkova, O. D. Ostroumova, E. V. Shikh, S. M. Rykova | ||
| "... in patients of the older age group of the therapeutic hospital, as well as combinations with other structural ..." | ||
| Vol 3, No 5 (2007) | BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME | Abstract similar documents |
| V. A. Nevzorova, N. V. Zakcharchuk, O. V. Nastradin, O. G. Pomogalova | ||
| "... were involved in the study. They were randomized in 2 groups, 10 patients in each group. Patients ..." | ||
| Vol 9, No 5 (2013) | LIPID METABOLISM CORRECTION BY ANTISENSE TECHNOLOGY | Abstract similar documents |
| O. I. Afanasieva, S. N. Pokrovsky | ||
| "... Antisense oligonucleotides (ASO) technology in elaboration of drugs for lipid metabolism ..." | ||
| Vol 5, No 6 (2009) | INFLUENCE OF ENALAPRIL, DIGOXIN, ATENOLOL AND DILTIAZEM ON LIPID PEROXIDATION IN EXPERIMENTAL MODEL OF COMPLEX METABOLIC DISORDERS | Abstract similar documents |
| A. A. Usanova, A. A. Aleksandrovsky, A. V. Zorkina, O. M. Kiselеv | ||
| "... Aim. To study influence of enalapril, digoxin, atenolol and diltiazem on lipid peroxidation ..." | ||
| Vol 9, No 4 (2013) | EFFECT OF SIMVASTATIN ON THE PROGNOSIS AND THE CHANGES OF THE CLINICAL STATUS IN PATIENTS WITH ACUTE ISCHEMIC STROKE. THE RESULTS OF THE 12 MONTH RANDOMIZED, OPEN COMPARATIVE STUDY | Abstract similar documents |
| V. V. Yakusevich, A. Yu. Malygin, A. V. Kabanov | ||
| "... , re- spectively (p=0.037). Lipid profile did not change significantly in group 1 while patients ..." | ||
| Vol 9, No 4 (2013) | EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE | Abstract PDF (Eng) similar documents |
| G. A. Batrak, S. E. Miasoedova, O. I. Kelesh | ||
| "... and target lipid levels achievement. Material and methods. The total of 161 type 2 diabetic patients ..." | ||
| Vol 8, No 5 (2012) | LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS | Abstract similar documents |
| A. N. Meshkov | ||
| "... Assessment of lipid-lowering effect of rosuvastatin is presented, as well as the main results ..." | ||
| Vol 17, No 1 (2021) | Lipid Clinic is an Efficacious Model of Preventive Medicine | Abstract PDF (Eng) similar documents |
| A. V. Blokhina, A. I. Ershova, A. N. Meshkov, A. S. Limonova, V. I. Mikhailina, O. M. Drapkina | ||
| "... Aim. To characterize patients accessing lipid clinic and assess the efficiency of treatment ..." | ||
| Vol 12, No 5 (2016) | Statins in Secondary Prevention of Atrial Fibrillation | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin | ||
| "... depending on the level of lipid metabolism: group I (n=33) received atorvastatin (10-40 mg/day), and control ..." | ||
| Vol 16, No 4 (2020) | Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice | Abstract similar documents |
| D. V. Nebieridze, N. M. Akhmedzhanov, S. A. Davitashvili, A. S. Lishuta, A. S. Safaryan | ||
| "... The high prevalence of lipid metabolism disorders in the Russian population and their contribution ..." | ||
| Vol 10, No 2 (2014) | ASSESSMENT OF THE EFFECTIVENESS OF EDUCATIONAL PROGRAMS IN PATIENTS WITH METABOLIC SYNDROME | Abstract similar documents |
| L. L. Kirichenko, K. V. Ovsyannikov, S. A. Tochilkina, A. P. Korolev, S. N. Strelkova | ||
| "... with metabolic syndrome (MS). Material and methods. Patients with MS (n=68) were randomized into two groups ..." | ||
| Vol 13, No 3 (2017) | TREATMENT OF ARTERIAL HYPERTENSION AND DYSLIPIDEMIA IN REAL CLINICAL PRACTICE. THE SYNERGY STUDY. Part 2 | Abstract similar documents |
| O. M. Drapkina, A. S. Luishuta | ||
| "... ) measurements, and lipid blood levels were taken from the patient's medical records. Results. 1736 patients (53 ..." | ||
| Vol 14, No 5 (2018) | Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
| Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal | ||
| "... were randomized from first 24-hour of admission to either atorvastatin 80 mg daily (group 1 ..." | ||
| Vol 8, No 4 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpygina | ||
| "... groups. The patients were randomized into two groups: the group 1 (n=53) started treatment ..." | ||
| Vol 13, No 5 (2017) | IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS? | Abstract similar documents |
| A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova | ||
| "... . In the groups, evaluation of the achievements of target BP values and lipid variables, risk factors correction ..." | ||
| Vol 11, No 5 (2015) | Three-year dynamics and unsolved problems of lipid-lowering therapy | Abstract similar documents |
| V. A. Sergeeva | ||
| "... Aim. To study the lipid-lowering therapy, the adequacy of its control, as well as the awareness ..." | ||
| Vol 17, No 6 (2021) | Unsolved Issues of Atherosclerosis Prevention and of Adequate Lipid-lowering Therapy in Patients with Acute Ischemic Cerebrovascular Accident | Abstract similar documents |
| S. A. Boytsov, M. A. Piradov, M. M. Tanashyan, I. A. Voznjouk, M. V. Ezhov, E. V. Oschepkova, I. V. Sergienko, N. A. Shamalov, S. N. Yanishevskiy | ||
| "... of atherothrombotic genesis, namely lipid metabolism disorders, the modern evidence base for lipid-lowering therapy ..." | ||
| Vol 8, No 5 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpigina | ||
| "... into randomized, an open-label comparative stepped trial. The patients were randomized into two groups: the group ..." | ||
| Vol 13, No 4 (2017) | USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA | Abstract similar documents |
| O. M. Drapkina, A. S. Lishuta | ||
| "... Aim. To study the antihypertensive and hypolipidemic effect of a group of drugs including ..." | ||
| Vol 4, No 4 (2008) | LOVASTATIN EFFECT ON VASCULAR REMODELING AND MYOCARDIAL SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. S. Kerimkulova, A. M. Noruzbaeva, O. S. Lunegova, B. Z. Imanov, M. A. Pavlenko, A. E. Mirrahimov, I. JU. Gottfried, E. M. Mirrahimov | ||
| "... groups. Patients of the 1st group (n=44) received lovastatin (20-60 mg daily) in addition ..." | ||
| Vol 5, No 2 (2009) | COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich | ||
| "... groups were comparable on the main clinical characteristics. Results. By the end of the study both ..." | ||
| Vol 8, No 6 (2012) | ASSESSMENT OF CORONARY ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH FIVE YEAR HISTORY OF MYOCARDIAL INFARCTION DEPENDING ON THE STATIN THERAPY COMPLIANCE | Abstract similar documents |
| A. I. Chesnikova, V. A. Safronenko, A. V. Hripun | ||
| "... ) with a five year history of MI were involved into the study. Patients were divided into two groups depending ..." | ||
| Vol 1, No 3 (2005) | PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE | Abstract similar documents |
| V. V. Yakusevich, M. E. Mozheiko, N. V. Sudareva, N. E. Semyonova | ||
| "... hypertension (AH); to evaluate dynamics of cerebral blood flow parameters and plasma lipid concentrations ..." | ||
| Vol 6, No 4 (2010) | EFFICACY OF VARIOUS DRUG FORMS OF LYCOPENE IN PATIENTS WITH DYSLIPIDEMIA | Abstract similar documents |
| P. Ya. Dovgalevsky, V. A. Klochkov, N. E. Chalyk, O. M. Ansimova, I. Petyaev | ||
| "... and high level of lipid peroxygenation (LPO). At the second step two groups of patients (n=28 and 31 ..." | ||
| Vol 19, No 2 (2023) | Outpatient Practice of Lipid-Lowering Therapy Prescription (According to the ARGO-3 Study) | Abstract similar documents |
| M. V. Ezhov, N. M. Akhmedzhanov, T. E. Kolmakova, A. V. Tyurina, A. I. Martynov | ||
| "... Aim. To study the frequency of prescriptions of various types of lipid-lowering therapy ..." | ||
| Vol 12, No 2 (2016) | LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) | Abstract similar documents |
| N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta | ||
| "... Aim. To study the features of lipid-lowering therapy with rosuvastatin in high and very high ..." | ||
| Vol 17, No 6 (2021) | PCSK9 Inhibitors in Clinical Practice: Experience of a Specialized Lipid Center | Abstract similar documents |
| A. V. Blokhina, A. I. Ershova, A. S. Limonova, O. V. Kopylova, A. N. Meshkov, O. M. Drapkina | ||
| "... of their treatment in a specialized lipid center. Material and methods. A retrospective analysis of the medical ..." | ||
| Vol 17, No 4 (2021) | Arterial hypertension and antihypertensive therapy in older patients. The agreed opinion of experts from the Russian Association of Gerontologists and Geriatricians, the Antihypertensive League, the National Society for Preventive Cardiology | Abstract similar documents |
| O. N. Tkacheva, Yu. V. Kotovskaya, N. K. Runikhina, E. V. Frolova, V. S. Ostapenko, N. V. Sharashkina, E. I. Baranova, S. V. Bulgakova, S. V. Villevalde, D. V. Duplyakov, A. N. Ilnitskiy, O. A. Kislyak, Zh. D. Kobalava, A. O. Konradi, S. V. Nedogoda, Ya. A. Orlova, N. V. Pogosova, K. I. Proshchaev, G. A. Chumakova | ||
| "... in these groups of patients indicate an increase in morbidity and mortality with lower blood pressure ..." | ||
| Vol 17, No 1 (2021) | Features of Risk Stratification, Diagnosis and Secondary Prevention in Patients with Multifocal Arterial Disease. Part 1: Risk Stratification and Diagnosis | Abstract similar documents |
| V. G. Grachev, S. S. Vedenskaya, O. G. Smolenskaya | ||
| "... Мультифокальное артериальное поражение (МФАП) часто встречается у пациентов с атеросклеротическими ..." | ||
| Vol 5, No 5 (2009) | INFLUENCE OF THE COMBINED ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND CEREBRAL BLOOD FLOW IN PATIENTS WITH METABOLIC SYNDROME | Abstract similar documents |
| E. M. Idrisova, T. P. Kalashnikova, I. Yu. Efimova | ||
| "... and lipid metabolism as well as cerebral blood flow in patients with metabolic syndrome (МS) Material ..." | ||
| Vol 7, No 3 (2011) | COMPARATIVE ANALYSIS OF ARTERIAL HYPERTENSION TREATMENT IN MEN AND WOMEN BASED ON THE RESULTS OF ACCORD STUDY (ACRIDILOLE IN COMBINATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY OR TYPE 2 DIABETES) | Abstract similar documents |
| S. A. Shalnova, S. Yu. Martsevich, A. D. Deev, Yu. V. Lukina, E. N. Hoseva | ||
| "... comparative open-label study in parallel groups. Patients were randomized into two groups. Patients of group ..." | ||
| Vol 9, No 3 (2013) | INFLUENCE OF ACARBOSE ON POSTPRANDIAL DYSMETABOLISM: RESULTS OF AN OPEN-LABEL RANDOMIZED STUDY | Abstract PDF (Eng) similar documents |
| A. Ya. Cherniak, I. M. Petrov, I. V. Medvedeva | ||
| "... Aim. To evaluate postprandial changes of lipid and glucose profiles, inflammation markers levels ..." | ||
| Vol 5, No 3 (2009) | COMPARATIVE CONTROLLED STUDY OF ANTIHYPERTENSIVE EFFICACY AND SAFETY OF CARVEDILOL IN PATIENTS WITH HYPERTENSION AND OBESITY OR DIABETES 2 TYPE (BASED ON RESULTS OF MULTICENTER TRIAL ACCORD) | Abstract similar documents |
| Yu. V. Yu.V. Lukina, S. Yu. Martsevich, A. D. Deev, S. A. Shalnova | ||
| "... ,001). Serum glucose and lipid spectrum did not change in both groups. Depression level decreased in patients ..." | ||
| Vol 6, No 2 (2010) | CHANGE IN BALANCE BETWEEN ACTIVITY OF LIPID PEROXIDATION, ANTIOXIDANT SYSTEM AND FERRUM CONTENT IN RATS WITH EXPERIMENTAL MYOCARDIAL INFARCTION | Abstract similar documents |
| L. D. Hidirova | ||
| "... Aim. To study the balance between activity of lipid peroxidation, antioxidant system and ferrum ..." | ||
| Vol 10, No 5 (2014) | EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION | Abstract similar documents |
| R. D. Kurbanov, N. U. Zakirov, Y. G. Kevorkova, N. B. Sayfiddinova | ||
| "... into the study after 10-14 days of the acute Q-MI onset. Determination of blood lipids profile, alanine ..." | ||
| Vol 1, No 2 (2005) | ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| M. V. Leonova, M. A. Demidova, A. V. Tarasov, Y. V. Belousov | ||
| "... , microalbuminuria and β2-microglobulinuria levels were defined, figures of lipid and glucose metabolism were studied ..." | ||
| Vol 17, No 2 (2021) | The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19 | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... and rosuvastatin is an effective drug that allows achieving not only adequate hypotensive and lipid-lowering ..." | ||
| Vol 9, No 4 (2013) | REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) | Abstract similar documents |
| S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy | ||
| "... from May, 1st till December, 31st, 2011 were divided into 3 groups: a control group (82 patients who ..." | ||
| Vol 7, No 5 (2011) | CLINICAL EFFICACY OF GLYCOSAMINOGLYCANS IN PATIENTS WITH DIABETES MELLITUS AND ISCHEMIC HEART DISEASE | Abstract similar documents |
| L. V. Kozlova, R. A. Khokhlov, N. M. Akhmedzhanov | ||
| "... into 2 groups: 56 patients of the main group were i/v administered sulodexide (Vessel Due F , “Alfa ..." | ||
| Vol 8, No 2 (2012) | CLINICAL IMPLICATION OF FATTY ACID CHANGES IN PATIENTS WITH PRIMARY GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| N. N. Kushnarenko, A. V. Govorin | ||
| "... acids levels in lipids of erythrocyte membranes in patients with primary gout associated with arterial ..." | ||
| Vol 18, No 3 (2022) | Aromatic Amino Acids: Phenylalanine and Tyrosine in Patients with Hypertension and Coronary Artery Disease | Abstract similar documents |
| A. V. Krivova, M. V. Kozhevnikova, E. O. Korobkova, V. Yu. Zektser, E. A. Zheleznykh, А. A. Ageev, N. E. Moskaleva, A. V. Kukharenko, S. A. Appolonova, Yu. N. Belenkov | ||
| "... participants were included in the hypertension group, 46 in the CАD group, and 27 participants without signs ..." | ||
| Vol 7, No 5 (2011) | COMPARATIVE EFFICACY AND SAFETY OF HYPOLIPIDEMIC THERAPY WITH GENERIC AND ORIGINAL MEDICINAL PRODUCTS OF SIMVASTATIN | Abstract similar documents |
| E. I. Tarlovskaya, Yu. A. Balandina, I. E. Sapozhnikova, N. S. Maksimchuk | ||
| "... into group A or group B. Patients of group A (n=18) received original simvastatin, patients of group B (n=20 ..." | ||
| Vol 19, No 2 (2023) | Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity? | Abstract similar documents |
| A. M. Chaulin, D. V. Duplyakov | ||
| "... numerous non-lipid effects of statin drugs can be divided into two groups: favorable and side effects ..." | ||
| Vol 6, No 5 (2010) | THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| S. N. Tereshchenko, N. G. Chuich, A. L. Syrkin, D. A. Andreev, A. V. Kolchurina, V. P. Terentev, A. Yu. Borozinets | ||
| "... cardioversion. Patients were randomized into 2 groups. Patients in Group 1 (n=30) received standard therapy ..." | ||
| Vol 4, No 2 (2008) | COMPARISON OF CARVEDILOL AND BISOPROLOL EFFICACY IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES TYPES 2 AFTER MYOCARDIAL INFARCTION | Abstract similar documents |
| M. E. Statsenko, S. V. Belenkova, O. E. Sporova, D. A. Ivanova, E. D. Evtereva | ||
| "... . Patients are randomized on 2 groups. All patients received basic therapy of CHF. Besides patients of 1st ..." | ||
| Vol 19, No 5 (2023) | Gender and age features of dyslipidemia in the population of the Nizhny Novgorod region | Abstract similar documents |
| N. Yu. Borovkova, V. K. Kurashin, A. S. Tokareva, T. E. Bakka, N. K. Pershina, E. S. Timoshchenko, A. A. Nekrasov, E. A. Ovchinnikova, N. N. Savickaya, M. A. Mironov, Yu. A. Balanova, A. E. Imaeva, A. V. Kontsevaya | ||
| "... , but in the middle (50-54 years) and older (60 years or more) age groups, this lipid metabolism disorder was observed ..." | ||
| Vol 6, No 4 (2010) | PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY) | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, A. D. Deev, S. A. Shalnova, R. G. Oganov | ||
| "... and randomly split in two groups. Patients of the first group (n=160) received carvedilol as a basic therapy ..." | ||
| Vol 6, No 3 (2010) | EFFECTS OF CALCIUM ANTAGONISTS OF THE THIRD GENERATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
| D. A. Yakhontov, N. F. Balabanova | ||
| "... on respiratory function, C reactive protein plasma level, glucose and lipid metabolism in patients with arterial ..." | ||
| Vol 7, No 6 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA | Abstract similar documents |
| V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich | ||
| "... with hyperlipidemia. Material and methods. Patients (6 men and 24 women) aged 38 to 77 years, which needed in lipid ..." | ||
| Vol 10, No 5 (2014) | THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE | Abstract similar documents |
| N. E. Zakirova, A. N. Zakirova | ||
| "... healthy subjects were included into control group. Myocardial remodeling was studied by echocardiography ..." | ||
| Vol 3, No 4 (2007) | EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE | Abstract similar documents |
| A. N. Zakirova, N. E. Zakirova, I. M. Karamova, N. Kh. Khafizov, O. V. Rasskazova | ||
| "... . They were randomized in two groups. The first group was presented with 43 patients receiving carvedilol ..." | ||
| Vol 14, No 2 (2018) | NEPHROPROTECTIVE EFFECTS OF LISINOPRIL IN THE THERAPY OF HYPERTENSIVE PATIENTS WITH OBESITY | Abstract similar documents |
| S. G. Shulkina, Е. N. Smirnova | ||
| "... without obesity). Control group was consisted of 50 healthy respondents without obesity. All HT patients ..." | ||
| Vol 14, No 3 (2018) | RELATION OF DISTURBANCES IN THE ERYTHROCYTES ELECTRICAL ACTIVITY WITH DYSLIPIDEMIA IN THE METABOLIC SYNDROME | Abstract similar documents |
| V. I. Podzolkov, T. V. Koroleva, A. E. Bragina, M. G. Kudryavtseva, G. I. Bragina, M. V. Pisarev | ||
| "... ) were examined. Control group consisted of healthy volunteers (n=25) of similar age. The level of EEC ..." | ||
| Vol 18, No 4 (2022) | Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, V. A. Metelskaya, V. A. Kutsenko, E. B. Yarovaya, A. V. Kapustina, G. A. Muromtseva, G. E. Svinin, Yu. A. Balanova, A. E. Imaeva, S. E. Evstifeeva, V. G. Vilkov, O. L. Barbarash, O. A. Belova, Yu. I. Grinshtein, A. Yu. Efanov, O. N. Kalachikova, N. V. Kulakova, O. P. Rotar, I. A. Trubacheva, D. V. Duplyakov, R. A. Libis, I. A. Viktorova, A. N. Redko, S. S. Yakushin, S. A. Boytsov, E. V. Shlyakhto, O. M. Drapkina | ||
| "... in ESSE RF (1) and 3.8 years in ESSE RF(2). Analysis was performed for three lipid variables: total ..." | ||
| Vol 13, No 4 (2017) | GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS | Abstract similar documents |
| M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava | ||
| "... Aim. To study the anti-inflammatory effects of intensive lipid-lowering therapy and genetic ..." | ||
| Vol 19, No 6 (2023) | New possibilities for lipid level control using inclisiran — prospects for interaction between a cardiologist and a neurologist | Abstract similar documents |
| A. B. Skiba, M. V. Menzorov, V. D. Puchek, I. M. Buchin, I. I. Polyakov, E. N. Menzorova | ||
| "... in the modern paradigm for dyslipidemia treatment from high-intensity statin therapy to high-intensity lipid ..." | ||
| Vol 3, No 5 (2007) | CUMULATIVE CARDIO-VASCULAR RISK IN HYPERTENSIVE PATIENTS: EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS | Abstract similar documents |
| L. I. Katelnitskaya, L. A. Haisheva, S. E. Glova | ||
| "... . Material and methods. 143 patients with arterial hypertension of 1-2 stages were split in 3 groups: 1st ..." | ||
| Vol 18, No 3 (2022) | Assessment of the Quality of Drug Therapy in Patients with Stable Coronary Artery Disease in the Second Stage of the ALIGN Study | Abstract similar documents |
| E. D. Zharkova, S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, O. M. Drapkina | ||
| "... , its compliance with clinical guidelines, achievement of lipid profile and blood pressure (BP) targets ..." | ||
| Vol 6, No 4 (2010) | CORRELATIONS OF LOW MOLECULAR WEIGHT PHENOTYPE OF APOPROTEIN(A) AND SERUM LEVEL OF LIPOPROTEIN(A) WITH MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE | Abstract similar documents |
| O. I. Afanasieva, M. V. Ezhov, M. I. Afanasieva, M. S. Safarova, J. V. Berestetskaya, S. N. Pokrovsky | ||
| "... and carotid atherosclerosis were split into two groups depending on the presence (n=22) or absence (n=198 ..." | ||
| Vol 16, No 1 (2020) | Metabolic, Inflammatory and Imaging Biomarkers in Evaluation of Coronary Arteries Anatomical Stenosis in Patients with Stable Coronary Artery Disease | Abstract PDF (Eng) similar documents |
| O. A. Koshelskaya, T. E. Suslova, I. V. Kologrivova, N. Y. Margolis, O. A. Zhuravleva, O. A. Kharitonova, I. V. Vinnitskaya | ||
| "... angiography was performed in all patients. Basic serum parameters of carbohydrate and lipid metabolism were ..." | ||
| Vol 1, No 2 (2005) | INFLUENCE OF MENOPAUSE ON BLOOD PRESSURE DIPPING IN WOMEN WITH METABOLIC SYNDROME: A CASE-CONTROL STUDY | Abstract similar documents |
| D. A. Anichkov, N. A. Shostak | ||
| "... was carried out, lipids and glucose of blood serum were studied. Results. Clinical parameters, characterizing ..." | ||
| Vol 15, No 5 (2019) | Association of rs556621 Polymorphism with Development of Stroke in Patients with Cardiovascular Pathology | Abstract similar documents |
| S. Yu. Nikulina, V. A. Shulman, A. A. Chernova, S. V. Prokopenko, D. A. Nikulin, I. M. Platunova, S. S. Tretyakova, V. N. Maksimov, A. A. Gurazheva | ||
| "... .0 [51.0-62.0]) and 272 patients (170 men and 102 women) of the control group (mean age 55.0 [51.0-62 ..." | ||
| 1 - 100 of 959 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
